Skip to main content

Metabolic Disease

2
Pipeline Programs
7
Companies
9
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Poxel
PoxelFrance - Lyon
1 program
1
PXL770Phase 11 trial
Active Trials
NCT03395470Completed60Est. Mar 2018
Oneness Biotech
Oneness BiotechTaiwan - Taipei City
1 program
1
SNS851Phase 11 trial
Active Trials
NCT07417124Recruiting52Est. Oct 2026
Innovation Pharmaceuticals
2 programs
ControlN/A1 trial
MealN/A1 trial
Active Trials
NCT03685916Completed20Est. Sep 2020
NCT02529228Completed10Est. Aug 2015
Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic AcidemiaN/A1 trial
Singapore PREconception Study of Long-Term Maternal and Child OutcomesN/A1 trial
Active Trials
NCT02890342Recruiting1,045Est. Aug 2036
NCT03531658Active Not Recruiting1,054Est. Dec 2029
Genome & Company
Genome & CompanyKorea - Suwon
1 program
Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic AcidemiaN/A
Bayer
BayerLEVERKUSEN, Germany
1 program
No drugN/A2 trials
Active Trials
NCT03579732Completed4,710,504Est. Sep 2019
NCT01450592Completed796Est. Sep 2012
Longeveron
LongeveronMIAMI, FL
1 program
Peripheral IntravenousPHASE_21 trial
Active Trials
NCT02587572Withdrawn0Est. Dec 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
LongeveronPeripheral Intravenous
Oneness BiotechSNS851
PoxelPXL770
BayerNo drug
Innovation PharmaceuticalsControl
Human BioSciencesNatural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia
Human BioSciencesSingapore PREconception Study of Long-Term Maternal and Child Outcomes
Innovation PharmaceuticalsMeal
BayerNo drug

Clinical Trials (9)

Total enrollment: 4,713,541 patients across 9 trials

NCT02587572LongeveronPeripheral Intravenous

Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial

Start: Dec 2023Est. completion: Dec 20230
Phase 2Withdrawn
NCT07417124Oneness BiotechSNS851

Assess the Safety and Tolerability of SNS851 in Healthy Participants

Start: Mar 2026Est. completion: Oct 202652 patients
Phase 1Recruiting
NCT03395470PoxelPXL770

Safety, Tolerability and PK of PXL770 in Healthy Male Subjects

Start: Aug 2017Est. completion: Mar 201860 patients
Phase 1Completed
NCT03579732BayerNo drug

EffectiveNess of Low Dose Aspirin in GastrointEstinal Cancer Prevention - Taiwan

Start: Jun 2018Est. completion: Sep 20194,710,504 patients
N/ACompleted
NCT03685916Innovation PharmaceuticalsControl

Screening of Phytochemical Rich Ingredients as 'Functional Foods' to Improve Cardiometabolic Health

Start: Apr 2018Est. completion: Sep 202020 patients
N/ACompleted
NCT02890342Human BioSciencesNatural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia

Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia

Start: Nov 2016Est. completion: Aug 20361,045 patients
N/ARecruiting
NCT03531658Human BioSciencesSingapore PREconception Study of Long-Term Maternal and Child Outcomes

Singapore PREconception Study of Long-Term Maternal and Child Outcomes

Start: Feb 2015Est. completion: Dec 20291,054 patients
N/AActive Not Recruiting
NCT02529228Innovation PharmaceuticalsMeal

Combined Effects of Meal Frequency and Protein Load on Cardiometabolic Risk Factors

Start: Dec 2014Est. completion: Aug 201510 patients
N/ACompleted
NCT01450592BayerNo drug

Study To Assess the Dietary Carbohydrate Content of Indian Diabetic Population

Start: May 2012Est. completion: Sep 2012796 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 4,713,541 patients
7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.